SECsense Logo

Zura Bio Limited 8-K Report: Key Insights and Financial Overview

$ZURA
Form 8-K
Filed on: 2025-02-24
Source
Zura Bio Limited 8-K Report: Key Insights and Financial Overview

Based on the provided XML section of the financial report, the following key information and insights can be extracted:

  1. Entity Information:
  • Company Name: Zura Bio Limited
  • CIK (Central Index Key): 0001855644
  • SEC Filing Type: 8-K
  • Filing Date: February 24, 2025
  • Company Address: 1489 W. Warm Springs Rd. #110, Henderson, NV 89014
  • Phone Number: 702-757-6133
  1. Stock Information:
  • Class of Shares: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  • Stock Exchange: NASDAQ (Ticker: ZURA)
  1. Financial Metrics:
  • Reporting Date: The report is for the date of February 24, 2025.
  • Currency: All amounts are reported in U.S. Dollars (USD).
  • Measurement Units: Financial metrics are reported in USD and shares.
  1. General Filing Context:
  • The filing appears to be an 8-K, which typically reports significant events that shareholders should be aware of. The specific details of the event are not included in the extracted data.

Insights:

  • As this is an 8-K filing, it indicates that Zura Bio Limited has likely reported a significant event or update that may impact the company's financial standing or operations.
  • The presence of Class A Ordinary Shares suggests that the company may have multiple classes of stock, which can be important for understanding shareholder rights and dividend distributions.
  • The filing date being in the future (2025) may indicate planned disclosures or updates pertaining to future events or financial results.

Overall, this information provides a snapshot of Zura Bio Limited's corporate structure and stock information, while the nature of the 8-K filing suggests potential developments or changes relevant to investors.